Longer diabetes duration correlated with older age, a higher proportion of females, a history of stroke, peripheral arterial disease, insulin use, and poorer kidney function
The addition of Wegovy in patients treated with insulin has not been evaluated Wegovy causes a delay of gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications
The clinical trials ran for 68 to 104 weeks for a reason, because the full effect of semaglutide takes time to manifest
It can certainly be used off-label for weight loss except for one problem it doesnt work
Youre not just protecting the medication, youre safeguarding your treatment outcomes
View the current altRx GLP-1 offer (official altRx page) Disclaimers Content and Medical Disclaimer: The information provided in this article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment